Cargando…
The DIVE/DPV registries: evolution of empagliflozin use in clinical practice in Germany
INTRODUCTION: Empagliflozin reduced morbidity and mortality in patients with type 2 diabetes mellitus (T2DM) in clinical trials. A registry study was undertaken to describe evolution of patient characteristics and assess the real-world effectiveness/safety of empagliflozin. RESEARCH DESIGN AND METHO...
Autores principales: | Bramlage, Peter, Tittel, Sascha R, Wagner, Christian, König, Kerstin, Raddatz, Dirk, Weber-Lauffer, Rosmarie, Erath, Diether, Hilgenberg, Jost, Spies, Carsten, Danne, Thomas, Gabler, Maximilian, Foersch, Johannes, Ley, Ludwin, Seufert, Jochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388887/ https://www.ncbi.nlm.nih.gov/pubmed/32719080 http://dx.doi.org/10.1136/bmjdrc-2020-001486 |
Ejemplares similares
-
Type 2 diabetes in older patients: an analysis of the DPV and DIVE databases
por: van Mark, Gesine, et al.
Publicado: (2020) -
Patient and disease characteristics of adult patients with type 1 diabetes in Germany: an analysis of the DPV and DIVE databases
por: van Mark, Gesine, et al.
Publicado: (2019) -
DIVE/DPV registries: benefits and risks of analog insulin use in individuals 75 years and older with type 2 diabetes mellitus
por: van Mark, Gesine, et al.
Publicado: (2021) -
An analysis of DPV and DIVE registry patients with chronic kidney disease according to the finerenone phase III clinical trial selection criteria
por: Bramlage, Peter, et al.
Publicado: (2023) -
Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases
por: Bramlage, Peter, et al.
Publicado: (2019)